Don’t miss the latest developments in business and finance.

Biocon, US firm launch breast cancer drug in India

Image
BS Reporter Mumbai
Last Updated : Jan 20 2013 | 9:47 PM IST

In October 2007, Abraxane was approved by the Drug Controller General of India. The approval was based on the clinical trial data that was the basis of approval in the US.

Also Read

First Published: Jul 18 2008 | 5:02 PM IST

Next Story